Immune system activation via local inflammatory response in the bladder wall

This entry does not represent a single molecule or canonical drug target, but rather a **complex network of innate and adaptive immune responses** that are triggered in the bladder wall in response to infection or injury. Key events include activation of bladder epithelial cells and resident immune cells (mast cells, macrophages, natural killer cells), release of cytokines, chemokines, and antimicrobial peptides, and recruitment of neutrophils and other immune cells to the site of infection or inflammation. The local immune activation is critical for both pathogen elimination and tissue repair, but when dysregulated, can lead to conditions such as interstitial cystitis/bladder pain syndrome or chronic cystitis. Current pharmacological interventions typically target the underlying triggers (such as infection) or modulate immune activation and inflammation to alleviate symptoms rather than targeting a specific molecule within this pathway.

Other names

Local inflammatory response in the bladder wallBladder wall immune activationBladder mucosal immune response

Reduction or modulation of immune and inflammatory signaling (above drug classes) Suppression of bacterial or viral infection Inhibition of mast cell degranulation